Atlas Trials

А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder

Clinical trial NCT04524975 · COMPLETED

Trial details

NCT number
NCT04524975
Sponsor
ChemRar Research and Development Institute, LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Anxiety Disorder Generalized
Start date
2018-10-02
Primary completion
2019-08-20
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.